Reagents and kits represent 69.0% of component type sales and clinical diagnostics account for 52.1% within the application segment in 2026. The proteomics market was valued at USD 44.8 billion in 2025, is projected to reach USD 94.3 billion by 2036 and is forecast to post a 7.0% CAGR between 2026 and 2036.